News

Dr Reddy’s stepping up focus on Indian market
Dr Reddy's Laboratories intensifies focus on Indian market with innovative drugs, collaborations, and digital therapeutics ...
Seeking Alpha8d
Dr. Reddy's Laboratories Limited (RDY) Q4 2025 Earnings Call Transcript
We appreciate your time and participation. Joining us today is the leadership team of Dr. Reddy's Limited, comprising Mr. Erez Israeli, our CEO; Mr. M V Narasimham, our CFO; and the Investor ...
Dr Reddy’s Q4 FY25 net up 21% at ₹1,587 cr on product launches, revenue growth
Pharma major Dr Reddy’s Laboratories Ltd’s consolidated net profit increased 21% in the fourth quarter ended March 31, 2025 ...
Devdiscourse8d
Dr Reddy's Laboratories Reports Robust Q4 Performance with 21% Profit Surge
Dr Reddy's Laboratories recorded a 21% increase in net profit for the March quarter, reaching Rs 1,587 crore, supported by ...